Chromadex Corp Total Operating Expenses Over Time
| CDXC Stock | USD 7.44 0.19 2.49% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Chromadex Corp Performance and Chromadex Corp Correlation. Chromadex |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromadex Corp. If investors know Chromadex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromadex Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.02 | Revenue Per Share 1.215 | Quarterly Revenue Growth 0.312 | Return On Assets 0.0051 | Return On Equity 0.0482 |
The market value of Chromadex Corp is measured differently than its book value, which is the value of Chromadex that is recorded on the company's balance sheet. Investors also form their own opinion of Chromadex Corp's value that differs from its market value or its book value, called intrinsic value, which is Chromadex Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromadex Corp's market value can be influenced by many factors that don't directly affect Chromadex Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chromadex Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chromadex Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromadex Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Operating Expenses Analysis
Compare Chromadex Corp and related stocks such as Ikena Oncology, Eliem Therapeutics, and HCW Biologics Total Operating Expenses Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IKNA | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 53.7 M | 65.1 M | 86.5 M | 84.6 M | 70.9 M |
| HCWB | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 9.9 M | 13.4 M | 17.7 M | 21 M | 15.3 M |
| XCUR | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 17.2 M | 20.1 M | 21.9 M | 27.9 M | 42 M | 62.1 M | 30.7 M | 14.1 M | 13.4 M |
| IPSC | 20 M | 20 M | 20 M | 20 M | 20 M | 20 M | 20 M | 20 M | 20 M | 20 M | 49.2 M | 94.9 M | 139 M | 56.1 M | 79 M |
| KZR | 9 M | 9 M | 9 M | 9 M | 9 M | 9 M | 9 M | 8.7 M | 24.7 M | 37.3 M | 43 M | 54.7 M | 71.2 M | 111.2 M | 116.7 M |
| MLYS | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 2.9 M | 18.7 M | 31.5 M | 84.7 M | 88.9 M |
| NKTX | 6.9 M | 6.9 M | 6.9 M | 6.9 M | 6.9 M | 6.9 M | 6.9 M | 6.9 M | 6.9 M | 22.5 M | 51.5 M | 86.4 M | 119 M | 131.7 M | 76.6 M |
| AVTE | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 8.9 M | 23 M | 53.2 M | 81.4 M | 85.5 M |
| ADAG | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 19.6 M | 19.6 M | 82.5 M | 93.2 M | 41.8 M | 50.6 M |
| ACRV | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 16.2 M | 32.7 M | 66.7 M | 70 M |
| RZLT | 42.7 K | 42.7 K | 6.1 M | 5.2 M | 10.7 M | 15 M | 20.3 M | 26.4 M | 25.9 M | 20.5 M | 22.4 M | 41.6 M | 56 M | 70.4 M | 73.9 M |
| ANTX | 5.2 M | 5.2 M | 5.2 M | 5.2 M | 5.2 M | 5.2 M | 5.2 M | 5.2 M | 5.2 M | 5.2 M | 7.3 M | 21.6 M | 42.3 M | 69.6 M | 73.1 M |
| ANEB | 173.4 K | 173.4 K | 173.4 K | 173.4 K | 173.4 K | 173.4 K | 173.4 K | 173.4 K | 173.4 K | 173.4 K | 3.6 M | 6.8 M | 11.8 M | 8.3 M | 6.8 M |
| JANX | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 3.8 M | 4.8 M | 36.6 M | 75.7 M | 81.1 M | 44.4 M |
| MNOV | 2 M | 16.1 M | 11.7 M | 10 M | 9.2 M | 8.8 M | 10.9 M | 13 M | 15.6 M | 14 M | 14.2 M | 14.3 M | 14.6 M | 10.9 M | 14.4 M |
Chromadex Corp and related stocks such as Ikena Oncology, Eliem Therapeutics, and HCW Biologics Total Operating Expenses description
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.My Equities
My Current Equities and Potential Positions
| Chromadex Corp | CDXC |
Specialization | Consumer Defensive, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 7.44
Check out Chromadex Corp Performance and Chromadex Corp Correlation. For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Chromadex Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.